Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term denosumab (Pralia) use and physical function in rheumatoid arthritis
jRCT2031210189Recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of denosumab in rheumatoid arthritis (RA), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: HAQ score change. Started Jun 2013; status: recruiting.
02
Drugs
denosumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT2031210189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210189.